Jefferies Initiates Amsurg With Buy

Analysts at Jefferies initiated coverage on

with a Buy rating. The target price for Amsurg is set to $65. Amsurg shares have jumped 35.95% over the past 52 weeks, while the S&P 500 index has gained 14.77% in the same period. Amsurg's shares rose 2.05% to close at $55.33 yesterday.